2016 Q4 Form 10-K Financial Statement

#000143774917005765 Filed on March 31, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $1.376M
YoY Change 42.52%
Cost Of Revenue $565.1K
YoY Change 98.32%
Gross Profit $810.9K
YoY Change 19.16%
Gross Profit Margin 58.93%
Selling, General & Admin $2.674M
YoY Change -2.24%
% of Gross Profit 329.71%
Research & Development $1.129M
YoY Change -48.06%
% of Gross Profit 139.18%
Depreciation & Amortization $100.0K $19.86K $80.00K
YoY Change 25.0% 449.78% 0.0%
% of Gross Profit 2.45%
Operating Expenses $4.127M
YoY Change -19.36%
Operating Profit -$3.316M
YoY Change -25.27%
Interest Expense $855.0K
YoY Change 113.83%
% of Operating Profit
Other Income/Expense, Net -$3.123M
YoY Change 738.25%
Pretax Income -$6.439M
YoY Change 33.86%
Income Tax
% Of Pretax Income
Net Earnings -$6.439M
YoY Change 33.86%
Net Earnings / Revenue -467.93%
Basic Earnings Per Share
Diluted Earnings Per Share -$59.83K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.0K $133.6K $150.0K
YoY Change -13.33% -12.66% -95.77%
Cash & Equivalents $133.6K $133.6K $152.9K
Short-Term Investments
Other Short-Term Assets $90.00K $87.82K $120.0K
YoY Change -25.0% -29.17% -7.69%
Inventory $232.0K $232.0K $284.9K
Prepaid Expenses $87.82K $124.0K
Receivables $460.8K $460.8K $74.45K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $914.1K $914.2K $636.3K
YoY Change 43.67% 43.67% -84.23%
LONG-TERM ASSETS
Property, Plant & Equipment $76.94K $76.94K $4.228K
YoY Change 1719.73% 1718.91% -46.07%
Goodwill
YoY Change
Intangibles $0.00 $306.8K
YoY Change -100.0% -50.0%
Long-Term Investments
YoY Change
Other Assets $13.79K $13.79K $11.10K
YoY Change 24.23% 24.23% -0.08%
Total Long-Term Assets $90.72K $90.72K $322.1K
YoY Change -71.83% -71.83% -49.07%
TOTAL ASSETS
Total Short-Term Assets $914.1K $914.2K $636.3K
Total Long-Term Assets $90.72K $90.72K $322.1K
Total Assets $1.005M $1.005M $958.4K
YoY Change 4.85% 4.85% -79.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $713.0K $713.0K $509.3K
YoY Change 40.0% 40.0% 119.66%
Accrued Expenses $375.1K $549.4K $359.4K
YoY Change 4.37% -34.65% -2.73%
Deferred Revenue
YoY Change
Short-Term Debt $47.44K $5.412M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.916M $7.916M $1.488M
YoY Change 431.99% 431.99% -76.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $5.350M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $5.350M
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.916M $7.916M $1.488M
Total Long-Term Liabilities $0.00 $0.00 $5.350M
Total Liabilities $7.916M $7.916M $6.836M
YoY Change 15.8% 15.8% 9.95%
SHAREHOLDERS EQUITY
Retained Earnings -$99.43M -$92.99M
YoY Change 6.92% 5.45%
Common Stock $137.2K $87.09M
YoY Change -99.84% 143306.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.912M -$6.912M -$5.878M
YoY Change
Total Liabilities & Shareholders Equity $1.005M $1.005M $958.4K
YoY Change 4.85% 4.85% -79.46%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income -$6.439M
YoY Change 33.86%
Depreciation, Depletion And Amortization $100.0K $19.86K $80.00K
YoY Change 25.0% 449.78% 0.0%
Cash From Operating Activities -$490.0K -$3.199M -$460.0K
YoY Change 6.52% -7.89% -59.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $10.36K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.590K $0.00
YoY Change -98.41%
Cash From Investing Activities $0.00 -$8.770K $0.00
YoY Change -108.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0K 3.208M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -490.0K -3.199M -460.0K
Cash From Investing Activities 0.000 -8.770K 0.000
Cash From Financing Activities 140.0K 3.208M 0.000
Net Change In Cash -350.0K -452.0 -460.0K
YoY Change -23.91% -99.99% -59.65%
FREE CASH FLOW
Cash From Operating Activities -$490.0K -$3.199M -$460.0K
Capital Expenditures $0.00 $10.36K $0.00
Free Cash Flow -$490.0K -$3.210M -$460.0K
YoY Change 6.52% -7.59% -59.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 snwv Class Of Warrant Or Right Change In Fair Value
ClassOfWarrantOrRightChangeInFairValue
2223718
CY2015 snwv Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2016 snwv Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
7571733
CY2015 snwv Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
15570852
CY2016 snwv Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
3576737
CY2016 snwv Class Of Warrant Or Right Gain Loss From Cashless Exercise During Period
ClassOfWarrantOrRightGainLossFromCashlessExerciseDuringPeriod
1242120
CY2015 snwv Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
3310000
CY2016 snwv Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
74633960
CY2015 snwv Class Of Warrant Or Right Value Issued During Period
ClassOfWarrantOrRightValueIssuedDuringPeriod
36990
CY2016 snwv Class Of Warrant Or Right Value Issued During Period
ClassOfWarrantOrRightValueIssuedDuringPeriod
34441
CY2016 snwv Class Of Warrant Or Rights Converted During The Period
ClassOfWarrantOrRightsConvertedDuringThePeriod
23701427
CY2016 snwv Class Or Warrant Or Right Value Of Warrants Converted During The Period
ClassOrWarrantOrRightValueOfWarrantsConvertedDuringThePeriod
1154139
CY2016 snwv Deferred Tax True Up
DeferredTaxTrueUp
CY2016Q4 snwv Accrued Audit And Tax Preparation
AccruedAuditAndTaxPreparation
100000
CY2015Q4 snwv Accrued Audit And Tax Preparation
AccruedAuditAndTaxPreparation
93500
CY2016Q4 snwv Accrued Board Of Director Fees
AccruedBoardOfDirectorFees
16000
CY2015Q4 snwv Accrued Board Of Director Fees
AccruedBoardOfDirectorFees
CY2016Q4 snwv Accrued Clinical Study Expenses
AccruedClinicalStudyExpenses
13650
CY2015Q4 snwv Accrued Clinical Study Expenses
AccruedClinicalStudyExpenses
22777
CY2016Q4 snwv Accrued Executive Severance
AccruedExecutiveSeverance
100000
CY2015Q4 snwv Accrued Executive Severance
AccruedExecutiveSeverance
100000
CY2016Q4 snwv Accrued Outside Services Current
AccruedOutsideServicesCurrent
31533
CY2015Q4 snwv Accrued Outside Services Current
AccruedOutsideServicesCurrent
58813
CY2015 snwv Class Of Warrant Or Right Change In Fair Value
ClassOfWarrantOrRightChangeInFairValue
-58516
CY2015 snwv Deferred Tax True Up
DeferredTaxTrueUp
1803402
CY2016 snwv Gain Loss On Warrant Valuation Adjustment And Conversion
GainLossOnWarrantValuationAdjustmentAndConversion
-2223718
CY2015 snwv Gain Loss On Warrant Valuation Adjustment And Conversion
GainLossOnWarrantValuationAdjustmentAndConversion
58515
CY2016Q4 snwv Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
109426
CY2015 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
CY2016 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
191231
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35196
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8963
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
31514
CY2015Q4 snwv Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
239803
CY2016 snwv Loss On Warrant Conversion To Stock
LossOnWarrantConversionToStock
888418
CY2015 snwv Loss On Warrant Conversion To Stock
LossOnWarrantConversionToStock
CY2014 snwv Payments Of Accrued Executive Severance Costs
PaymentsOfAccruedExecutiveSeveranceCosts
300000
CY2015 snwv Share Based Compensation Arrangement By Share Based Payment Award Options Cancel In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelInPeriod
2083445
CY2015 snwv Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePricePerShare
2.39
CY2016 snwv Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2015 snwv Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2016 snwv Warrants Issued During Period
WarrantsIssuedDuringPeriod
34441
CY2016 snwv Warrants Issued For Services
WarrantsIssuedForServices
186410
CY2015 snwv Warrants Issued For Services
WarrantsIssuedForServices
CY2016 snwv Warrants Issued For Short Term Debt
WarrantsIssuedForShortTermDebt
58400
CY2015 snwv Warrants Issued For Short Term Debt
WarrantsIssuedForShortTermDebt
CY2016 snwv Warrants Redeemed During Period
WarrantsRedeemedDuringPeriod
1154139
CY2016Q4 snwv Working Capital
WorkingCapital
-7002324
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
712964
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
509266
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
460799
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74454
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
375088
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
359374
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
45000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
76500
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
455227
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
459632
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52069
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33162
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-99433448
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-92994408
CY2016 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
186410
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12358
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
225786
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
306756
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
306757
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
94290134
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48376071
CY2016Q4 us-gaap Assets
Assets
1004870
CY2015Q4 us-gaap Assets
Assets
958361
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3394141
CY2016Q4 us-gaap Assets Current
AssetsCurrent
914146
CY2015Q4 us-gaap Assets Current
AssetsCurrent
636280
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
133571
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152930
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3547071
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19359
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
50563538
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
38302686
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
78086749
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137219968
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63056519
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137219968
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63056519
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
92436697
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
87086677
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6457947
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4830970
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentration of credit risk and limited suppliers</div></div> - Management routinely assesses the financial strength of its customers and, as a consequence, believes accounts receivable are stated at the net realizable value and credit risk exposure is limited. Two distributors accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32%</div> of revenues for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Two distributors accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29%</div> of revenues for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We depend on suppliers for product component materials and other components that are subject to stringent regulatory requirements. We currently purchase most of our product component materials from single suppliers and the loss of any of these suppliers could result in a disruption in our production. If this were to occur, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be difficult to arrange a replacement supplier because certain of these materials <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> only be available from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or a limited number of sources. In addition, establishing additional or replacement suppliers for these materials <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> take a substantial period of time, as certain of these suppliers must be approved by regulatory authorities.</div></div></div></div></div>
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
565129
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
284962
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
50100
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2016 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
191231
CY2015 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1367488
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1605319
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
7128
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2419
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
41341
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
18810
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-150246
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-176377
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
447626
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
443597
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30588629
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29078023
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
28777
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
35156
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27839703
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26451449
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
120451
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
127578
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
13933
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
20158
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
24030
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
90442
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2038638
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1834172
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
75471
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
75471
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30588629
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29078023
CY2016 us-gaap Depreciation
Depreciation
19858
CY2015 us-gaap Depreciation
Depreciation
3612
CY2016Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
1242120
CY2015Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
138100
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18907
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-20685
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Embedded Derivative Loss On Embedded Derivative
EmbeddedDerivativeLossOnEmbeddedDerivative
8171
CY2015 us-gaap Embedded Derivative Loss On Embedded Derivative
EmbeddedDerivativeLossOnEmbeddedDerivative
24631
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64860
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
241542
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2223718
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-58515
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3502135
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3195379
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3502135
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3502135
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
306756
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12329
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18832
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1594
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
100000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2673773
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2735129
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1510606
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-24125
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
17077
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
12330
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2253664
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1683600
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
220597
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
31666
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-160335
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-119778
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
203698
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
277426
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
412578
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18005
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15714
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10082
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-176682
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
239316
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-130377
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
157939
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
29249
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7916470
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1488085
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3207771
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8770
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
100000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3199453
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13037
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2689
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-36165
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4562
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
306756
CY2016 us-gaap Interest Expense
InterestExpense
854980
CY2015 us-gaap Interest Expense
InterestExpense
399832
CY2016 us-gaap Interest Paid
InterestPaid
630549
CY2015 us-gaap Interest Paid
InterestPaid
242904
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
218592
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
290623
CY2016Q4 us-gaap Inventory Gross
InventoryGross
308213
CY2015Q4 us-gaap Inventory Gross
InventoryGross
378073
CY2016Q4 us-gaap Inventory Net
InventoryNet
231953
CY2015Q4 us-gaap Inventory Net
InventoryNet
284908
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
89621
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
87450
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
76260
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
93165
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
43540
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2016Q4 us-gaap Liabilities
Liabilities
7916470
CY2015Q4 us-gaap Liabilities
Liabilities
6836197
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1004870
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
958361
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11097
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-20685
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-18907
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18907
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20685
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3473456
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-6439040
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-4810285
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3122541
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-372507
CY2016Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
4923723
CY2015Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
4844792
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5364572
CY2015Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
CY2015Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
5348112
CY2016Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
CY2015Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
5348112
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016 us-gaap Operating Expenses
OperatingExpenses
4127433
CY2015 us-gaap Operating Expenses
OperatingExpenses
5118317
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-3316499
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-4437778
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
683222
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
115486
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
148288
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
143969
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
139775
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
135704
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
178073
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
155926
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8754
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7784
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13786
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10364
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
137220
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
63057
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
87823
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
123988
CY2016 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1528200
CY2015 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1596855
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1594
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
100000
CY2016 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
100000
CY2015 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
67466
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
532165
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
463860
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76938
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4228
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
16666
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.55
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.37
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26233
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-6055
CY2016 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.08
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1128640
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2172819
CY2016 us-gaap Revenues
Revenues
1376063
CY2015 us-gaap Revenues
Revenues
965501
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
547842
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
504534
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0128
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0142
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.3354
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.2063
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16203385
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.38
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4950000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6130000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7206830
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10073385
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16203385
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.62
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.38
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.35
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
914542
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
175002
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2015 us-gaap Stock Issued1
StockIssued1
CY2016Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
435392
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.36
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y321D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
5672874
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
6305002
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.36
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.11
CY2016Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
47440
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
CY2016 us-gaap Stock Issued1
StockIssued1
43540
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
43540
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1596855
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
504534
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
547842
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-6911600
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-5877836
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-1551400
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Estimates</div></div> &#x2013; These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of assets and liabilities, and correspondingly revenues and expenses, depend on future events, the preparation of consolidated financial statements for any period necessarily involves the use of estimates and assumptions. Actual amounts <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> differ from these estimates. These consolidated financial statements have, in management&#x2019;s opinion, been properly prepared within reasonable limits of materiality and within the framework of the accounting policies summarized herein. Significant estimates include the recording of allowances for doubtful accounts, estimated reserves for inventory, valuation of derivatives, accrued expenses, the determination of the valuation allowances for deferred taxes, estimated fair value of stock-based compensation, estimated fair value of warrant liabilities and the estimated fair value of intangible assets.</div>
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1510606
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1779277
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
159626
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
138100
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
107619869
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63025202

Files In Submission

Name View Source Status
0001437749-17-005765-index-headers.html Edgar Link pending
0001437749-17-005765-index.html Edgar Link pending
0001437749-17-005765.txt Edgar Link pending
0001437749-17-005765-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snwv-20161231.xml Edgar Link completed
snwv-20161231.xsd Edgar Link pending
snwv-20161231_cal.xml Edgar Link unprocessable
snwv-20161231_def.xml Edgar Link unprocessable
snwv-20161231_lab.xml Edgar Link unprocessable
snwv-20161231_pre.xml Edgar Link unprocessable
snwv20161231_10k.htm Edgar Link pending